We are live on ! Find out more
UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Portfolio holdings

AUM $863M
1-Year Est. Return 30.35%
This Fund
S&P 500
This Quarter Est. Return
+3.04%
1 Year Est. Return
+30.35%
3 Year Est. Return
+68.34%
5 Year Est. Return
+24.17%
10 Year Est. Return
–
AUM
$260M
AUM Growth
+$6.01M
Cap. Flow
-$1.45M
Cap. Flow %
-0.56%
Top 10 Hldgs %
99.53%
Holding
19
New
4
Increased
6
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$148K
2
VOE icon
Vanguard Morningstar Mid-Cap Value ETF
VOE
+$131K
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$120K
4
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$113K
5
VNQ icon
Vanguard Real Estate ETF
VNQ
+$61.8K

Top Sells

Rank Stock Value
1
SYRE icon
Spyre Therapeutics
SYRE
+$1.81M
2
APEN
Apollo Endosurgery, Inc.
APEN
+$317K
3
AAPL icon
Apple
AAPL
+$2K

Sector Composition

Rank Sector Weight
1 Healthcare 2.07%
2 Technology 1.36%
3 Utilities 0%
4 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
State Street SPDR S&P 500 ETF Trust
SPY
$809B
$237M 91.15%
872,645
– –
SYRE icon
2
Spyre Therapeutics
SYRE
$9.18B
$3.6M 1.39%
13,627
-7,370
-35% -$1.81M
TXN icon
3
Texas Instruments
TXN
$253B
$3.53M 1.36%
32,000
– –
VEA icon
4
Vanguard FTSE Developed Markets ETF
VEA
$238B
$3.29M 1.27%
76,600
+3,316
+5% +$148K
VOO icon
5
Vanguard S&P 500 ETF
VOO
$1.03T
$3.13M 1.21%
12,561
+485
+4% +$120K
VOE icon
6
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.4B
$3.04M 1.17%
27,538
+1,182
+4% +$131K
VWO icon
7
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$2.48M 0.96%
58,881
+2,492
+4% +$113K
VDE icon
8
Vanguard Energy ETF
VDE
$10.4B
$1.24M 0.48%
11,773
+328
+3% +$33.6K
VNQ icon
9
Vanguard Real Estate ETF
VNQ
$38.6B
$862K 0.33%
10,581
+797
+8% +$61.8K
BPTH
10
DELISTED
Bio-Path Holdings Inc
BPTH
$571K 0.22%
958
– –
APEN
11
DELISTED
Apollo Endosurgery, Inc.
APEN
$477K 0.18%
68,293
-50,907
-43% -$317K
LXRX icon
12
Lexicon Pharmaceuticals
LXRX
$1.05B
$429K 0.17%
35,714
– –
PLXP
13
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$244K 0.09%
62,673
– –
GILD icon
14
Gilead Sciences
GILD
$168B
$60K 0.02%
+850
New +$60K
IJH icon
15
iShares Core S&P Mid-Cap ETF
IJH
$128B
$5K ﹤0.01%
+125
New +$4.83K
IWO icon
16
iShares Russell 2000 Growth ETF
IWO
$15B
$5K ﹤0.01%
+23
New +$4.6K
POR icon
17
Portland General Electric
POR
$5.74B
$5K ﹤0.01%
118
– –
VZ icon
18
Verizon
VZ
$195B
$3K ﹤0.01%
+54
New +$2.61K
AAPL icon
19
Apple
AAPL
$4.41T
– –
-56
Closed -$2K

Similar funds

WFAL
Wedbush Fund Advisers, LLC Pasadena, California $863M AUM
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
OMG
One Madison Group New York $866M AUM 33.81% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
RWM
RMG Wealth Management Platteville, Wisconsin $866M AUM 11.95% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
HP
Havemeyer Place Greenwich, Connecticut $867M AUM
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s Q2 2018 Portfolio in Review

As of Q2 2018, University of Texas/Texas AM Investment Management Co (UTIMCO) held 19 positions worth $260M, up 2.4% from $254M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

University of Texas/Texas AM Investment Management Co (UTIMCO)'s Q2 2018 filing shows 4 new, 6 increased, 2 reduced and 1 closed positions. Its largest new stake was Gilead Sciences: 850 shares worth $60K. The largest sale was Spyre Therapeutics, an estimated $1.81M.

By sector, the portfolio is most concentrated in Healthcare at 2.1% of assets, down from 2.9% a quarter earlier, followed by Technology and Utilities.

  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s largest Q2 2018 buy was Gilead Sciences: 850 shares worth $60K.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) added most to Vanguard FTSE Developed Markets ETF in Q2 2018, an estimated $148K increase.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s biggest Q2 2018 reduction was Spyre Therapeutics, cutting an estimated $1.81M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) fully exited Apple in Q2 2018, selling an estimated $2K.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s ten largest holdings make up 100% of its $260M portfolio in Q2 2018.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) opened 4 new positions and closed 1 in Q2 2018.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio value rose 2.4% quarter-over-quarter to $260M.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q2 2018, filed 7 Aug 2018.